Supreme Court restores access to abortion pill

• But it's likely to reduce confusion among pharmacies, telehealth firms and providers over what's allowed, even in states where abortion is legal.

Driving the news: The stay was in response to requests from drugmakers Danco Laboratories and GenBioPro to restore access to mifepristone via teleprescribing and the mails.

• Responses from parties in the underlying case have until Thursday to file responses.

The order was in response to a 5th Circuit ruling on Friday, which sided with Louisiana in a case challenging Biden administration rules that expanded access to mifepristone.

• Louisiana argued the federal rules undermined its laws protecting unborn human life and caused it to spend Medicaid funds on emergency care for women harmed by mifepristone.
• Abortion opponents have targeted the teleprescribing of abortion pills since Roe v. Wade was overturned and pressed the Trump administration to restore in-person dispensing requirements.
• The Food and Drug Administration is conducting a safety review of mifepristone. Last fall, the agency approved a new generic version of mifepristone, angering abortion foes.

This story has been updated with additional reporting